These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hepatic Transcriptome and Its Regulation Following Soluble Epoxide Hydrolase Inhibition in Alcohol-Associated Liver Disease. Warner JB; Hardesty JE; Song YL; Floyd AT; Deng Z; Jebet A; He L; Zhang X; McClain CJ; Hammock BD; Warner DR; Kirpich IA Am J Pathol; 2024 Jan; 194(1):71-84. PubMed ID: 37925018 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice. Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748 [TBL] [Abstract][Full Text] [Related]
7. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress. Ren Q; Ma M; Ishima T; Morisseau C; Yang J; Wagner KM; Zhang JC; Yang C; Yao W; Dong C; Han M; Hammock BD; Hashimoto K Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1944-52. PubMed ID: 26976569 [TBL] [Abstract][Full Text] [Related]
8. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress. Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080 [TBL] [Abstract][Full Text] [Related]
10. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease. Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides. López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510 [TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia. Bettaieb A; Koike S; Hsu MF; Ito Y; Chahed S; Bachaalany S; Gruzdev A; Calvo-Rubio M; Lee KSS; Inceoglu B; Imig JD; Villalba JM; Zeldin DC; Hammock BD; Haj FG Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2758-2765. PubMed ID: 28757338 [TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase inhibitor attenuates BBB disruption and neuroinflammation after intracerebral hemorrhage in mice. Tian Y; Yuan X; Wang Y; Wu Q; Fang Y; Zhu Z; Song G; Xu L; Wang W; Xie M Neurochem Int; 2021 Nov; 150():105197. PubMed ID: 34592333 [TBL] [Abstract][Full Text] [Related]
16. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis. Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of the Src homology phosphatase 2 confers partial protection in a mouse model of alcohol-associated liver disease. Hsu MF; Koike S; Chen CS; Najjar SM; Meng TC; Haj FG Biomed Pharmacother; 2024 Jun; 175():116590. PubMed ID: 38653109 [TBL] [Abstract][Full Text] [Related]